Daicel Corporation

Daicel Corporation

DACHF
Daicel CorporationUS flagOther OTC
8.00
USD
- -
- -
2.04BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1,177.02
1,263.11
1,283.54
1,269.43
1,346.74
1,387.69
1,284.52
1,301.27
1,559.19
1,836.54
2,023.29
2,150.77
2,206.35
1,124.53
Basic EPS, GAAP
64.98
88.95
115.02
124.61
107.81
105.38
15.49
65.18
104.14
138.87
202.43
181.44
38.75
102.18
Free Cash Flow per Basic Share
47.65
79.08
84.36
138.91
97.32
44.61
33.85
69.7
-14.92
-85.6
27.27
77.24
-0.68
- -
Dividend per Share
13.01
17
25.98
26.07
33.2
32.19
32.39
34.44
32.14
36.36
46.62
55.63
60.57
- -
Book Value per Share
624.3
705.18
795.82
873.3
955.25
986.38
958.47
625.2
702.31
821.98
978.69
1,063.4
1,029.76
1,100.24
Tangible Book Value per Share
802.67
976.11
1,019.62
1,124.45
1,178
1,225.64
1,179.91
774.99
897.91
1,021.45
1,322.02
1,336.21
1,367.65
1,494.93
Basic Weighted Avg Shares
352
351
350
347
344
335
321
302
300
293
276
273
263
255
Sales/Revenue/Turnover
413,786
443,775
449,878
440,061
462,956
464,859
412,826
393,568
467,937
538,026
558,056
586,531
579,629
287,052
Operating Margin (%)
9.16
11.56
14.3
14.61
12.73
11.01
7.18
8.06
10.83
8.83
11.18
10.4
7.26
12.47
Depreciation Expense
25,091
25,633
25,969
30,836
32,956
31,050
30,119
27,404
28,195
31,575
33,703
41,373
43,343
- -
Net Income, GAAP
22,843
31,252
40,313
43,198
37,062
35,301
4,978
19,713
31,254
40,682
55,834
49,480
10,180
26,083
Effective Tax Rate (%)
36.3
31.82
26.67
22.13
24.93
21.97
31.31
32.1
30.74
24.24
25.63
22.93
56.26
25.81
Profit Margin (%)
5.52
7.04
8.96
9.82
8.01
7.59
1.21
5.01
6.68
7.56
10.01
8.44
1.76
9.09
Working Capital
145,152
167,216
174,161
197,889
231,033
228,529
191,814
199,958
206,349
185,771
200,677
185,273
205,583
213,511
LT Debt
71,630
64,896
58,709
59,983
75,884
76,043
72,200
255,571
236,029
208,823
214,741
208,021
239,984
227,703
Total Equity
295,804
356,176
368,720
399,428
413,540
423,242
392,582
245,000
279,542
310,433
375,407
375,035
370,377
392,309
Return on Invested Capital (%)
6.23
8.13
10.48
10.81
8.88
7.61
4.01
4.3
6.49
6
7.06
6.97
2.73
3.95
Return on Capital (%)
6.04
7.6
9.33
9.41
7.09
6.43
-0.15
3.99
6.52
7.61
9.72
8.54
1.75
4.56
Return on Common Equity (%)
10.86
13.38
15.31
14.85
11.74
10.72
1.56
7.93
15.63
18.02
21.86
17.67
3.63
9.82

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
85,049
- -
54,532
LT Borrowings
214,741
- -
227,703
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
276
- -
276
Market Capitalization
368,557
350,105
312,613

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
409,481
- -
385,089
Cash, Cash Equivalents & STI
73,183
- -
64,793
Accounts Receivable, Net
114,412
- -
100,291
Inventories
182,510
- -
184,069
Total Current Liabilities
208,804
- -
171,578
Payables & Accruals
- -
- -
- -
ST Debt
85,049
- -
54,532
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.41%
8.95%
-1.24%
Free Cash Flow
33.15%
57.59%
-100.85%
Net Income, GAAP
23.35%
7.03%
-79.43%
Sales/Revenue/Turnover
2.91%
8.3%
-1.18%
Total Cash Common Dividend
6.32%
9.33%
4.89%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
130,802
140,202
143,272
143,780
558,056
2025
- -
- -
- -
- -
586,531
2026
- -
- -
- -
- -
579,629

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
52.46
- -
- -
- -
202.43
2025
- -
- -
- -
- -
181.44
2026
- -
- -
- -
- -
38.75

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
46.62
2025
- -
- -
- -
- -
55.63
2026
- -
- -
- -
- -
60.57

Company Description

APIChatGPT
CEO
Yasuhiro Sakaki
Full Time Employees
11,134
Sector
Basic Materials
Industry
Chemicals - Specialty
Address
Grand Front Osaka Tower-B Osaka Japan 530-0011
IPO Date
Oct 2, 2012
Website
daicel.com
Business
Daicel Corporation, a leading Japanese chemical manufacturer founded in 1919 and headquartered in Osaka with key offices in Tokyo, produces advanced materials and specialty chemicals for industries including electronics, healthcare, automotive, and consumer goods; its core products encompass acetic acid and derivatives, cellulose derivatives such as cellulose acetate and acetate plastics, engineering plastics including polyacetal (POM), polybutylene terephthalate (PBT), polyphenylene sulfide (PPS), liquid crystal polymer (LCP), and cyclic olefin copolymer (COC), performance films, polymers and solvents for photoresists and electronic materials, optical lenses, cycloaliphatic epoxies, caprolactone derivatives, chiral chromatography columns and separation services, bioprocess purification systems, ultrafiltration membrane modules, and drug delivery devices like Actranza Lab. The company operates globally with subsidiaries such as Daicel Miraizu Ltd. for AS resin and barrier films, Novacel Co., Ltd. for ABS resins, and Daicel Pack Systems Ltd. for molded containers, serving markets in Japan, North America, Europe, China, and Asia. In recent developments, Daicel proceeds with the absorption-type acquisition of its wholly-owned subsidiary Polyplastics Co.'s entire business to integrate engineering plastics operations and enhance synergies under its Accelerate 2025 strategy, following Polyplastics' conversion to full ownership in 2020 and record profits; it also agreed to acquire the remaining 65% stake in Toyama Filter Tow Co., Ltd. from Mitsubishi Chemical Corporation, launched collaborations such as with Nagase & Co. on digital transformation for manufacturing processes and with ITRI to support startups, and expanded production capacity with a new COC plant in Kaohsiung starting February 2025 and another in Germany by TOPAS Advanced Polymers in April 2026.